tripelennamine has been researched along with Deficiency Diseases in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Deficiency Diseases: A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Patients with hereditary angioneurotic edema are unresponsive to intradermal injections of C'1 esterase immediately after attacks." | 1.25 | Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema. ( Donaldson, VH; Klemperer, MR; Rosen, FS, 1968) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klemperer, MR | 1 |
Donaldson, VH | 1 |
Rosen, FS | 1 |
1 other study available for tripelennamine and Deficiency Diseases
Article | Year |
---|---|
Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.
Topics: Adult; Angioedema; Antigen-Antibody Reactions; Cell Membrane Permeability; Complement System Protein | 1968 |